A significant proportion of childhood cancer survivors develop serious health problems as young adults, especially those who received radiation therapy
A significant proportion of childhood cancer survivors
develop serious health problems as young adults, especially those who received
radiation therapy, according to an article in the June 27 issue of the Journal
of the American Medical Association.
The introduction of more effective treatments for childhood
cancer has dramatically improved survival rates, but this has been accompanied
by the occurrence of late, treatment-related complications such as second cancers,
organ dysfunction, and psychosocial and cognitive problems. Information is limited
on the occurrence and risk of subsequent illnesses among adults who had cancer
as children, according to background information in the article.
Huib N. Caron, MD, PhD, of Emma Children’s Hospital/Academic
Medical Center, Amsterdam, and colleagues conducted a study to assess the total
burden of adverse health outcomes following childhood cancer treated at a single
Dutch medical center between 1966 and 1996. Researchers examined 1,362 five-year
survivors to characterize adverse events. Medical follow-up was completed for
94.3 percent of survivors (median follow-up, 17.0 years). At the end of follow-up
the median age of the survivors was 24.4 years, with 88 percent of survivors younger
than 35 years.
The researchers found that of the 1,362 survivors, 19.8
percent had no adverse events, 74.5 percent had one or more events, and 24.6 percent
had five or more events. Additionally, 36.8 percent had at least one severe or
life-threatening or disabling disorder, and 3.2 percent died due to an adverse
event. Almost 22 percent of adverse events were severe, life-threatening or disabling,
or caused death. Of those events, orthopedic disorders occurred most often, followed
by second tumors, obesity, fertility disorders, psychosocial or cognitive disorders,
neurologic disorders and endocrine disorders.
Of all patients treated with radiotherapy only, 55 percent
had a high or severe burden of events (defined as at least two severe events or
one or more life-threatening or disabling event) compared with 15 percent of patients
treated with chemotherapy only and 25 percent of patients who had surgery only.
Survivors of bone tumors most often had a high or severe
burden of events (64 percent), while survivors of leukemia or Wilms tumor least
often had a high or severe burden of events (12 percent each).
“In conclusion, childhood cancer survivors are at increased
risk of many severe health problems, resulting in a high burden of disease during
young adulthood. This will inevitably affect the survivors’ quality of life and
also will ultimately reduce their life expectancy. Therefore, we feel that risk-stratified
lifelong medical surveillance of childhood cancer survivors is needed to allow
early detection of adverse events that are amenable to intervention. Future studies
should focus on the efficacy of follow-up programs and other intervention strategies
for adverse events, to further improve health outcomes in survivors of childhood
cancer,” the authors wrote.
|